ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,648.45
0.31%
US Tech 100
19,816.80
-0.15%
Dow Jones
40,786.47
1.43%
Brent Oil
83.425
-1.08%
Bitcoin
64,764.90
-0.13%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Crism Therapeutics Corporation (CRTX)

  7. Crism Therapeutics Corporation (CRTX) News

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:CRTX
DateTimeSourceHeadlineSymbolCompany
07/03/20242:03PMAlliance NewsAlliance NewsIN BRIEF: Crism flags contract talks, reacts to share price surgeLSE:CRTXCrism Therapeutics Corporation
07/03/202411:18AMRNS Regulatory NewsCrism Therapeutics Corporation Response to Movement in Share PriceLSE:CRTXCrism Therapeutics Corporation
06/03/202410:25AMRNS Regulatory NewsCrism Therapeutics Corporation Director DealingLSE:CRTXCrism Therapeutics Corporation
05/31/20244:58PMAlliance NewsAlliance NewsIN BRIEF: Crism has first day of trade on AIM after name change, buyLSE:CRTXCrism Therapeutics Corporation
05/31/20242:00AMRNS Regulatory NewsCrism Therapeutics Corporation Admission to Trading and First Day of DealingsLSE:CRTXCrism Therapeutics Corporation
12/18/20091:45PMPR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010NASDAQ:CRTX
11/20/20093:40PMPR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalNASDAQ:CRTX
11/16/20098:00AMPR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceNASDAQ:CRTX
11/13/20098:00AMPR Newswire (US)Cornerstone Therapeutics Appoints General CounselNASDAQ:CRTX
11/04/20097:00AMPR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:CRTX
10/21/20098:00AMPR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallNASDAQ:CRTX
09/03/20098:01AMPR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)NASDAQ:CRTX
09/03/20098:00AMPR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:CRTX
07/20/20098:00AMPR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalNASDAQ:CRTX
07/15/20097:04PMPR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductNASDAQ:CRTX
07/08/20094:15PMPR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tNASDAQ:CRTX
06/12/20094:35PMDow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
06/12/20093:28PMDow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
05/19/20094:01PMPR Newswire (US)Cornerstone Therapeutics Announces Management ChangeNASDAQ:CRTX
05/07/20097:01AMPR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpANASDAQ:CRTX
05/07/20097:00AMPR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsNASDAQ:CRTX
04/27/20098:00AMPR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallNASDAQ:CRTX
01/13/20095:33PMDow Jones NewsUPDATE: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
01/13/20093:34PMDow Jones NewsFDA: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
11/05/20088:00AMPR Newswire (US)Cornerstone Therapeutics Announces New Board of DirectorsNASDAQ:CRTX
08/01/200610:00AMPR Newswire (US)Critical Therapeutics Files Controlled Release Formulation of ZileutonNASDAQ:CRTX
 Showing the most relevant articles for your search:LSE:CRTX

Your Recent History

USOTC
AXXA
Exxe (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
WDLF
Decentral Life (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
COOP
Mr Cooper
COIN
XRPUSD
Ripple
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
HIRU
Hiru (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
NB
NioCorp Developments
USOTC
ENZC
Enzolytics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved